<SEC-DOCUMENT>0001193125-25-119914-index.html : 20250514
<SEC-HEADER>0001193125-25-119914.hdr.sgml : 20250514
<ACCEPTANCE-DATETIME>20250514164713
ACCESSION NUMBER:		0001193125-25-119914
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20250514
DATE AS OF CHANGE:		20250514
EFFECTIVENESS DATE:		20250514

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Acrivon Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001781174
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				825125532
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-287277
		FILM NUMBER:		25946645

	BUSINESS ADDRESS:	
		STREET 1:		480 ARSENAL WAY, SUITE 100
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472
		BUSINESS PHONE:		617-207-8979

	MAIL ADDRESS:	
		STREET 1:		480 ARSENAL WAY, SUITE 100
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>d901324ds8.htm
<DESCRIPTION>S-8
<TEXT>
Document 1 - file: d901324ds8.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>2
<FILENAME>d901324dex43.htm
<DESCRIPTION>EX-4.3
<TEXT>
Document 2 - file: d901324dex43.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>d901324dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 3 - file: d901324dex51.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>4
<FILENAME>d901324dex232.htm
<DESCRIPTION>EX-23.2
<TEXT>
Document 4 - file: d901324dex232.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>5
<FILENAME>d901324dexfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
Document 5 - file: d901324dexfilingfees.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g901324dsp1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: g901324dsp1.jpg

</DOCUMENT>
</SEC-DOCUMENT>